65,437 trials
Pulmonary Disease, Chronic Obstructive
Primary: Percentage of Participants Who Continuously Received Triple Therapy for 6 Months — 92.5 Percentage of participants
COVID-19 Vaccination
Primary: AST Normal to Abnormal Transition — 2.0; 2.6 % of participants who transitioned — p=1.000
Postpartum Depression
Primary: Depression Symptoms — 10.1; 11 score on a scale
Pediatric Disorder · Neonatal Disease
Primary: Parent FCR Attendance — 0.56; 0.12 proportion of encounters
Chronic Kidney Disease
Primary: Change in Short Physical Performance Battery Score — -1 units on a scale — p=0.73
Cataract
Primary: Mean Anterior Chamber Cell/Flare Score — 1.06; 1.15 Units on a scale
Risk Behavior · HIV/AIDS · Medication Adherence
Primary: Pre-exposure Prophylaxis (PrEP) Adherence Behavior — 25.9; 22.8 score
Reproductive Health
Primary: Changes in Frequency of Unprotected Intercourse (Youth) — 1.42; 1.16; 1.38 number of occassions — p=<.05
Hearing Loss · Hearing Loss, Conductive · Hearing Loss, Unilateral
Primary: Overall IOI-HA Score — 3.98; 3.96; 3.86; 4.02 score on a scale
Cardiac Surgery Intensive Care Treatment · Delayed Recovery From Anaesthesia · Euthyroid Sick Syndrome
Primary: Change in Glasgow Coma Scale (GCS) From Intervention Initiation to ICU Discharge (Δ) — 6.65; 2.69 Score on a scale
Attention Deficit Hyperactivity Disorder (ADHD) · Anxiety Disorders and Symptoms
Primary: The Average Change in the Total Score Across the "Inattention" and "Hyperactivity/Impulsivity" Subscales of the Swanson, Nolan and Pelham Teacher and Parent Rating Scale…
Hearing Loss
Primary: Oxygenation Using Functional Near Infrared Spectroscopy (fNIRS) — -14.85; 4.15 Oxygenation (uMol)
Stroke
Primary: Feasibility as Assessed by the Number of Sessions Attended — 11.06 sessions
Cardiovascular Diseases
Primary: Difference in Mean Change in Prime Diet Quality Score Between Groups Between Months 0 and 6 — 1.22 Units on a scale
Neonatal · Premature Birth · Respiratory Distress Syndrome
Primary: Alveolar Volume — 500.2; 418.1 mL — p=<0.05